<p>The “Tumor Immunology Meets Oncology” (TIMO XIX) meeting 2025 reports on the rapidly growing field of basic, but in particular translational tumor immunology thereby providing deeper insights into the heterogeneity of tumors, their microenvironment and clinical relevance. This represents the basis for the development of novel immunotherapeutic strategies and combinatorial therapies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

“Tumor Immunology Meets Oncology” (TIMO), 22 May–24 May 2025 in Brandenburg an der Havel, Germany

  • Barbara Seliger

摘要

The “Tumor Immunology Meets Oncology” (TIMO XIX) meeting 2025 reports on the rapidly growing field of basic, but in particular translational tumor immunology thereby providing deeper insights into the heterogeneity of tumors, their microenvironment and clinical relevance. This represents the basis for the development of novel immunotherapeutic strategies and combinatorial therapies.